(Q30413422)

3 November 2017

Identifying specific chemotherapeutic agents in Medicare data: a validation study (English)

1 reference

3 November 2017

0 references

0 references

5

Robert S Sandler

1 reference

3 November 2017

2

Til Stürmer

1 reference

3 November 2017

6

Maurice Alan Brookhart

1 reference

3 November 2017

4

Hanna K Sanoff

1 reference

3 November 2017

1

Jennifer L Lund

1 reference

3 November 2017

7

Joan L Warren

1 reference

3 November 2017

Linda C Harlan

3

1 reference

3 November 2017

1 May 2013

1 reference

3 November 2017

1 reference

3 November 2017

51

1 reference

3 November 2017

5

1 reference

3 November 2017

e27-34

1 reference

Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer.

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Outcomes of irinotecan-based chemotherapy regimens in elderly Medicare patients with metastatic colorectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

American Society of Clinical Oncology guidance statement: the cost of cancer care

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Risk of subsequent dementia diagnoses does not vary by types of adjuvant chemotherapy in older women with breast cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Temporal trends in the management of potentially resectable lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Residual treatment disparities after oncology referral for rectal cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Survival benefits and trends in use of adjuvant therapy among elderly stage II and III rectal cancer patients in the general population

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Agreement of diagnosis and its date for hematologic malignancies and solid tumors between medicare claims and cancer registry data

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Completion of therapy by Medicare patients with stage III colon cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

External validation of medicare claims for breast cancer chemotherapy compared with medical chart reviews

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Utility of the SEER-Medicare data to identify chemotherapy use.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Construct validity of medicare chemotherapy claims: the case of 5FU.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Risk of hospitalizations associated with adverse effects of chemotherapy in a large community-based cohort of elderly women with ovarian cancer

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Etiology of delays in the initiation of adjuvant chemotherapy and their impact on outcomes for Stage II and III rectal cancer

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Risk of dementia in older breast cancer survivors: a population-based cohort study of the association with adjuvant chemotherapy

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Sample size calculation should be performed for design accuracy in diagnostic test studies

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3290707

Racial disparities in treatment and survival of male breast cancer

26 November 2018

1 reference

12 December 2020

The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer

1 reference

12 December 2020

Acute Myeloid Leukemia After Adjuvant Breast Cancer Therapy in Older Women: Understanding Risk

1 reference

12 December 2020

Racial and socioeconomic disparities in adjuvant chemotherapy for older women with lymph node-positive, operable breast cancer

1 reference

12 December 2020

Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer

1 reference

12 December 2020

Surgical complications are associated with omission of chemotherapy for stage III colorectal cancer

1 reference

12 December 2020

Use and Outcomes of Adjuvant Chemotherapy in Older Women With Breast Cancer

1 reference

12 December 2020

Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort

1 reference

12 December 2020

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women

1 reference

12 December 2020

Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer

1 reference

12 December 2020

10.1097/MLR.0B013E31823AB60F

Identifiers

DOI

1 reference

3 November 2017

1 reference

PMC publication ID

3290707

3 November 2017

PubMed publication ID

22080337

1 reference

PMC publication ID

3290707